<DOC>
	<DOCNO>NCT00183274</DOCNO>
	<brief_summary>This study ass effectiveness venlafaxine XR , randomize either venlafaxine XR placebo prevent relapse generalize anxiety disorder 6 month treatment versus 12 month treatment .</brief_summary>
	<brief_title>Effectiveness Long-Term Versus Short-Term Treatment Generalized Anxiety Disorder With Venlafaxine XR</brief_title>
	<detailed_description>Generalized anxiety disorder ( GAD ) highly prevalent , chronic psychiatric disorder . Despite fact GAD frequently demand prolonged treatment medication , little known benefit long-term treatment . GAD characterize 6 month exaggerate worry tension unfounded much severe normal anxiety people experience . People GAD unable relax often suffer insomnia . Venlafaxine XR , drug use treat depression , show effective short-term treatment GAD . However , benefit course 8 week assess . This study evaluate effectiveness venlafaxine XR treat GAD long-term basis prevent relapse GAD 6 month treatment versus 12 month treatment . Participants double-blind study first receive 6 month open-label treatment venlafaxine XR . Upon completion initial phase , participant randomly assign either continue venlafaxine XR begin take placebo . After 12 month , participant take venlafaxine XR randomly assign continue drug switch placebo . Participants 22 study visit least 18 month . Follow-up visit occur 24 month enrollment . Relapse GAD assess Hamilton Anxiety Scale Global Severity Improvement Scale . A variety method , include questionnaire standardized scale , use assess secondary outcome .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Serotonin Noradrenaline Reuptake Inhibitors</mesh_term>
	<mesh_term>Norepinephrine</mesh_term>
	<criteria>GAD diagnosis structure interview Hamilton Anxiety Scale score 18 MORE Clinical Global Impressions Severity Scale score least 4 Hamilton Depression Scale score 18 less Hamilton Depression Scale suicide item score less 2 Use effective form contraception throughout study Hypersensitivity venlafaxine XR History seizures Episode major depressive disorder previous 6 month History psychotic illness , bipolar disorder , dementia Substance abuse dependence past 6 month Other anxiety disorder exception social phobia long GAD primary Regular use anxiolytic antidepressant within 7 day study onset Use fluoxetine monoamine oxidase inhibitor within 28 day study onset ( low dose usage benzodiazepine prevent participation ) Use psychotropic medication besides benzodiazepine study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Generalized Anxiety Disorder</keyword>
	<keyword>Chronic Mediation Treatment</keyword>
	<keyword>Double-Blind</keyword>
	<keyword>Placebo Controlled</keyword>
	<keyword>Venlafaxine XR</keyword>
	<keyword>Relapse</keyword>
</DOC>